Gonorrhoea: Clinical Trials

4 trials for Gonorrhoea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow Gonorrhoea: new trials by email Literature Review of Gonorrhoea trials Research Report on Gonorrhoea

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety, Tolerability and Plasma PK of a Single Oral Dose of Zoliflodacin in Healthy Male and Female Volunteers
AZD0914 - Gonorrhoea
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)82018-02-022019-03-18
Cefixime / Azithromycin pK Study
Azithromycin, Cefixime - Gonorrhoea
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)102016-04-282017-09-15
Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin
Solithromycin - Gonorrhoea
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)282015-05-052019-01-28
The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot Study
Cefixime - Gonorrhoea
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)252013-12-012019-01-17

Narrower conditions

Gonorrhea (4)  ·  Disease Susceptibility (1)

Broader conditions

Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Communicable Diseases (4)  ·  Genital Diseases (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Infections (4)  ·  Neisseriaceae Infections (4)  ·  Sexually Transmitted Diseases (4)  ·  Sexually Transmitted Diseases, Bacterial (4)  ·  Urogenital Diseases (4)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Cefixime (2)  ·  Azithromycin (1)  ·  solithromycin (1)  ·  zoliflodacin (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (4)

Countries

United States (4)

Results publications

PMID 29624558